Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 7Terminated 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 4Ovarian Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Neurofibrosarcoma 1Mesothelioma, Malignant 1Malignant mesenchymal tumor 1Ichthyosis, X-Linked 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

Trabectedin 2Doxorubicin 2sodium thiosulfate 1plitidepsin 1milademetan 1avelumab 1atezolizumab 1X-Rays 1TTI-621 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Platinum 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1Hyperthermic Intraperitoneal Chemotherapy 1Gene Expression Profiling 1Cytoreduction Surgical Procedures 1Cyproheptadine 1Cisplatin 1Blotting, Western 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Liposarcoma × Trabectedin × Clear all
NCT04979442 2025-01-14

MANTRA

Rain Oncology Inc

Phase 3 Terminated
175 enrolled 16 charts
Sarcoma

Liposarcoma, Sarcoma

NCT03074318 2022-04-29

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
35 enrolled 21 charts
Sarcoma

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡